Wednesday, January 31, 2018 2:15:15 PM
Sandusky, OH (GLOBE NEWSWIRE) - (via OTC PR WIRE) - Rising India, Inc.’s (OTC:RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that its laboratory in Ohio is close to completion in line with the State of Ohio issuing MMJ licenses.
“Now that Ohio is beginning to issue licenses, we plan on being fully operational in our medical marijuana laboratory, which will focus on research, development, licensing and manufacturing of innovative products in the Cannabis space dedicated to serving patients with the highest standards,” states COO Arthur Hall.
“We are also thrilled to announce that included in a line of medical cannabis products, the company is debuting Cannophen™, a revolutionary product we’ve been developing for some time now. Cannophen™ is an oral capsule with laboratory controlled metered dosing that can be blended in exacting ratios of THC, CBD and strain specific tirpenes. It is easily digestible and fast acting and designed for patients that do not want to smoke/vape or use off-tasting tinctures. This allows patients to take their medicine by swallowing a flavorless capsule, just like any other oral medication. We are also pleased to announce a new MMJ version of the TSW pain cream containing Cannabidiol (CBD).”
Hall adds, “There has never been any proper way to dose with the above said methods. We have developed Cannophen™ using the strictest quality and control standards and methods set forth in the pharmacy compounding industry using experienced chemists and veteran pharmacists.”
As well, Rising Biosciences is nearing completion on its FDA testing of the TSW (This Sh** Works) pain cream products.
“We’ve also had stellar feedback from those that received trial samples of the Clinical Strength Scar Peptide Serum and we now move into the next phase of production,” concludes Hall.
“Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opiods on America through the responsible use of cannabis”
https://www.laboratorynetwork.com/doc/rising-biosciences-inc-develops-groundbreaking-oral-thc-cbd-delivery-capsule-0001
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM